Clinical Trial Update: Eplerenone in HIV Associated Abdominal Fat Accumulation [NA]

View source ↗

Summary

A clinical trial evaluating eplerenone for HIV-associated abdominal fat accumulation has completed, and the study results were posted on 2018-05-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Lipodystrophy

Drugs mentioned

• Inspra (Eplerenone) (Eplerenone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV | NA | Status: COMPLETED | Results posted: 2018-05-16